Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Sep 15 · above the Ichimoku cloud · RSI 64 · MACD below its signal · 6% below its 52-week high
None of the 29 investors followed here reported a position in TECN.SW in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a TECN.SW trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for TECN.SW.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.8 | 0.1 | -2.1 | -11.8 | 32.0 | 4.1 | 15.0 | 6.2 | 18.6 | 2.7 | +87.4% | ||
| 2025 | 16.5 | -17.2 | -14.6 | -4.3 | 2.6 | -1.2 | 0.1 | 1.9 | -13.5 | 2.7 | -5.7 | -7.2 | −36.6% |
| 2024 | -3.1 | 3.7 | 8.4 | -12.5 | -2.3 | -5.8 | 8.8 | -12.9 | -2.3 | -21.7 | -3.6 | -3.6 | −41.0% |
| 2023 | -7.4 | -0.3 | 4.8 | -2.9 | -10.1 | -1.6 | 0.9 | 1.9 | -12.4 | -15.8 | 22.5 | 7.6 | −16.7% |
| 2022 | -19.4 | -11.2 | -7.5 | -19.7 | 5.1 | -10.8 | 21.4 | 7.3 | -5.0 | 7.1 | 6.6 | 5.3 | −25.8% |
| 2021 | -0.4 | -11.5 | 9.7 | 6.1 | 0.5 | 2.6 | 14.0 | 6.9 | -4.8 | 5.4 | -2.1 | 1.3 | +28.1% |
| 2020 | 0.3 | -1.3 | 7.9 | 7.2 | 7.8 | 0.0 | 14.4 | 6.4 | 12.4 | -5.2 | -8.5 | 8.9 | +59.5% |
| 2019 | 5.1 | 12.9 | 3.7 | -2.2 | 4.6 | 5.4 | -0.1 | -6.1 | 0.3 | -2.2 | 15.2 | 1.3 | +42.6% |
| 2018 | 1.7 | -3.9 | 2.1 | 8.3 | 6.4 | 3.4 | 4.3 | -7.9 | 0.3 | -2.2 | -9.7 | -7.0 | −5.9% |
| 2017 | -2.6 | 8.2 | -4.4 | 6.1 | 7.8 | -1.5 | 0.1 | 6.3 | 4.5 | 5.3 | -3.9 | 0.0 | +27.6% |
| 2016 | -9.6 | 5.0 | -5.5 | -8.8 | 10.4 | 3.3 | 2.6 | -0.5 | 9.9 | -4.3 | -1.4 | -1.1 | −2.5% |
| 2015 | -17.9 | 23.1 | 11.6 | -2.5 | 1.4 | -11.1 | 5.7 | 5.2 | 10.2 | -1.7 | 12.9 | 7.0 | +44.2% |
| 2014 | -5.7 | 6.1 | 0.4 | 3.6 | -2.7 | -5.1 | 2.0 | -0.4 | -2.4 | 0.9 | 6.7 | 4.4 | +7.1% |
| 2013 | 12.7 | -4.2 | 7.8 | -2.8 | -1.2 | 2.2 | 2.5 | 7.2 | -0.4 | -0.5 | 5.7 | 5.1 | +37.9% |
| 2012 | 5.8 | 9.5 | -9.6 | 3.8 | -8.5 | 3.6 | 3.7 | -4.1 | 4.8 | 1.8 | 0.0 | 10.1 | +20.5% |
| 2011 | 3.0 | -0.5 | -9.4 | -0.6 | -3.7 | 1.4 | -5.4 | 2.0 | -3.9 | -14.9 | 4.6 | 9.4 | −18.6% |
| 2010 | -3.2 | -1.3 | 8.7 | -11.1 | -6.0 | 1.6 | -4.8 | -5.3 | 7.5 | 2.8 | 3.9 | 9.6 | +0.0% |
| 2009 | -1.8 | -16.4 | -4.7 | 19.7 | 17.8 | -1.5 | 8.6 | 23.9 | 12.3 | -1.6 | 9.4 | 13.2 | +100.0% |
| 2008 | -20.7 | 11.2 | -0.3 | 14.2 | 2.6 | -2.4 | -16.4 | 10.0 | -11.8 | -6.3 | -13.8 | -13.0 | −42.6% |
| 2007 | 16.4 | -12.4 | 10.8 | 4.2 | -3.8 | -4.8 | -13.5 | 1.8 | 3.3 | 3.3 | -9.5 | -3.0 | −11.1% |
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Buy / hold / sell counts
No recent headlines.